Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any autosomal dominant non-syndromic intellectual disability in which the cause of the disease is a mutation in the ZBTB18 gene.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 10 | Seizure, Generalized non-motor (absence) seizure, Severe intellectual disability |
Growth and development | 4 | Short stature, Proportionate short stature, Intrauterine growth retardation |
Head and neck | 3 | Thin upper lip vermilion, Round face, Microcephaly |
Muscles | 2 | Low muscle tone (hypotonia), Generalized hypotonia |
Digestive system | 2 | Gastroesophageal reflux, Feeding difficulties |
Pregnancy and birth | 1 | Fetal pyelectasis |
Arms and legs | 1 | Stereotypical hand wringing |
ZBTB18 function has not been fully characterized.
Intellectual disability, autosomal dominant 22 is associated with mutations in the ZBTB18 gene on chromosome 1.
Genetic testing for ZBTB18 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for intellectual disability, autosomal dominant 22 has been reported in the published literature.
Phenotype severity distribution: 21 always present features.
No clinical trials have been registered for intellectual disability, autosomal dominant 22.
24 publications have been identified in PubMed for intellectual disability, autosomal dominant 22. Research spans Case Report / Case Series (30%), Review / Meta-Analysis (26%), and Basic Science / Preclinical (22%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 7 | 30% |
Research summaries | 6 | 26% |
Laboratory research | 5 | 22% |
Disease patterns and progression | 3 | 13% |
Testing and diagnosis research | 1 | 4% |
Clinical study results | 1 | 4% |
Wu Y (2026). [PMID: 42183389](https://pubmed.ncbi.nlm.nih.gov/42183389/). *Int J Pediatr*. [Case Report / Case Series]
Musante L (2026). [PMID: 41709284](https://pubmed.ncbi.nlm.nih.gov/41709284/). *Genome medicine*. [Basic Science / Preclinical]
Kumar S (2026). [PMID: 41576029](https://pubmed.ncbi.nlm.nih.gov/41576029/). *PLoS Genet*. [Basic Science / Preclinical]
Kennedy JT (2026). [PMID: 41549404](https://pubmed.ncbi.nlm.nih.gov/41549404/). *Alzheimer's & dementia : the journal of the Alzheimer's Association*. [Diagnostic / Biomarker]
Harripaul R (2026). [PMID: 41865132](https://pubmed.ncbi.nlm.nih.gov/41865132/). *Sci Rep*. [Basic Science / Preclinical]
Ates K (2026). [PMID: 42204957](https://pubmed.ncbi.nlm.nih.gov/42204957/). *Dev Neurobiol*. [Review / Meta-Analysis]
He Y (2026). [PMID: 41574619](https://pubmed.ncbi.nlm.nih.gov/41574619/). *Int J Dev Neurosci*. [Case Report / Case Series]
Mammadova N (2026). [PMID: 42053849](https://pubmed.ncbi.nlm.nih.gov/42053849/). *Mol Biol Rep*. [Case Report / Case Series]
Moses RG (2025). [PMID: 40519070](https://pubmed.ncbi.nlm.nih.gov/40519070/). *American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics*. [Basic Science / Preclinical]
Yeter B (2025). [PMID: 40742416](https://pubmed.ncbi.nlm.nih.gov/40742416/). *European journal of pediatrics*. [Case Report / Case Series]
Data assembled from 5 of 12 sources · Last updated Oct 3, 2026, 8:12 PM UTC
Online Mendelian Inheritance in Man